Related Experiment Video
Updated: Jul 12, 2026
12:05
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
Case 37: Neutropenia and macrocytosis in a middle-aged man
Sarah E Mangles1, Saad H Abdalla, Carolyn M Gabriel
1Department of Haematology, St Mary's Hospital, London, UK.
Leukemia & Lymphoma
|September 6, 2007
Summary
Myelodysplastic syndrome (MDS) can be mistaken for other conditions, delaying diagnosis. Promptly ruling out treatable causes of neutropenia and macrocytosis is vital for accurate patient management.
Area of Science:
- Hematology
- Internal Medicine
- Oncology
Background:
- Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
- Cytopenias and dysplasia are common presenting features of MDS.
- Differential diagnosis of MDS requires careful exclusion of other causes of blood count abnormalities.
Observation:
- A middle-aged man presented with neutropenia and macrocytosis.
- The initial suspicion of myelodysplastic syndrome (MDS) was not confirmed.
- A correct non-neoplastic diagnosis was delayed by 5 years.
Findings:
- The case highlights diagnostic challenges in differentiating MDS from other conditions causing neutropenia and macrocytosis.
- Delayed diagnosis can result from overlooking treatable non-neoplastic causes of cytopenias.
- Accurate and timely diagnosis is essential for appropriate patient care.
Implications:
- Emphasizes the importance of a thorough diagnostic workup for suspected MDS.
- Underscores the need to consider and exclude treatable non-neoplastic conditions.
- Highlights potential pitfalls in the diagnostic pathway for hematological disorders.
Related Concept Videos
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...